Harvesting techniques of the saphenous vein graft for coronary artery bypass: Insights from a network meta-analysis.

coronary artey bypass grafting endoscopic vein harvesting no-touch vein harvesting saphenous vein

Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Nov 2021
Historique:
revised: 19 07 2021
received: 25 05 2021
accepted: 08 08 2021
pubmed: 3 9 2021
medline: 5 10 2021
entrez: 2 9 2021
Statut: ppublish

Résumé

The optimal harvesting technique of saphenous vein (SVG) in coronary artery bypass grafting (CABG) is still to be elucidated. The present study aimed to compare the methods of SVG harvesting technique, which were open vein harvesting (OVH), endoscopic vein harvesting (EVH), and no-touch vein harvesting (NT), using a network meta-analysis of randomized controlled trials (RCTs), and propensity-score matched (PSM) studies. MEDLINE and EMBASE were searched through April 2021 to identify RCTs and PSM studies that investigated the outcomes in patients who underwent CABG with the SVG using one of three methods; OVH, EVH, and NT. The outcomes of interest were all-cause mortality, the rates of revascularization, and graft failure. Risk ratios (RRs) were extracted for the rates of graft failure, and hazard ratios (HRs) were extracted for all-cause mortality and the rates of revascularization. Eligible seven RCT and five PSM studies were identified which enrolled a total of 8111 patients. All-cause mortality was significantly lower in patients with EVH compared with OVH (HR [95% confidence interval (CI)] =0.77 [0.65-0.92], p = .0032). The rates of revascularization were similar among the groups. The rate of graft failures was significantly lower in patients with NT compared with OVH (HR [95% CI] =0.54 [0.32-0.90], p = .019) and with EVH (HR [95% CI] =0.39 [0.17-0.86], p = .023). NT vein harvesting is favorable for graft patency, and OVH showed higher all-cause mortality than EVH. Further well-powered RCTs are needed to confirm our findings.

Identifiants

pubmed: 34472140
doi: 10.1111/jocs.15974
doi:

Types de publication

Journal Article Meta-Analysis Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4369-4375

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961-972.
Caliskan E, de Souza DR, Böning A, et al. Saphenous vein grafts in contemporary coronary artery bypass graft surgery. Nat Rev Cardiol. 2020;17(3):155-169.
van Diepen S, Brennan JM, Hafley GE, et al. Endoscopic harvesting device type and outcomes in patients undergoing coronary artery bypass surgery. Ann Surg. 2014;260(2):402-408.
Williams JB, Peterson ED, Brennan JM, et al. Association between endoscopic vs open vein-graft harvesting and mortality, wound complications, and cardiovascular events in patients undergoing CABG surgery. JAMA. 2012;308(5):475-484.
Zenati MA, Bhatt DL, Bakaeen FG, et al. Randomized trial of endoscopic or open vein-graft harvesting for coronary-artery bypass. N Engl J Med. 2019;380(2):132-141.
Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med. 2009;151:W65-W94.
Higgins JP, Altman DG, Gøtzsche PC, et al. The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital Research Institute. Accessed January 28, 2018. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp
Kiaii B, Moon BC, Massel D, et al. A prospective randomized trial of endoscopic versus conventional harvesting of the saphenous vein in coronary artery bypass surgery. J Thorac Cardiovasc Surg. 2002 Feb;123(2):204-212.
Yun KL, Wu Y, Aharonian V, et al. Randomized trial of endoscopic versus open vein harvest for coronary artery bypass grafting: six-month patency rates. J Thorac Cardiovasc Surg. 2005;129(3):496-503.
Andreasen JJ, Vadmann H, Oddershede L, et al. Decreased patency rates following endoscopic vein harvest in coronary artery bypass surgery. Scand Cardiovasc J. 2015;49(5):286-292.
Samano N, Geijer H, Liden M, et al. The no-touch saphenous vein for coronary artery bypass grafting maintains a patency, after 16 years, comparable to the left internal thoracic artery: a randomized trial. J Thorac Cardiovasc Surg. 2015;150(4):880-888.
Pettersen Ø, Wiseth R, Hegbom K, Nordhaug DO, Nordhaug DO. Pedicled vein grafts in coronary surgery exhibit reduced intimal hyperplasia at 6 months. J Am Coll Cardiol. 2016;68(4):427-429.
Deb S, Singh SK, de Souza D, et al. SUPERIOR SVG: no touch saphenous harvesting to improve patency following coronary bypass grafting (a multi-Centre randomized control trial, NCT01047449). J Cardiothorac Surg. 2019;14(1):85.
Ad N, Henry L, Hunt S, et al. Endoscopic versus direct vision for saphenous vein graft harvesting in coronary artery bypass surgery. J Cardiovasc Surg (Torino). 2011;52(5):739-748.
Dacey LJ, Braxton JH, Jr., Kramer RS, et al. Long-term outcomes of endoscopic vein harvesting after coronary artery bypass grafting. Circulation. 2011;123(2):147-153.
Grant SW, Grayson AD, Zacharias J, et al. What is the impact of endoscopic vein harvesting on clinical outcomes following coronary artery bypass graft surgery? Heart. 2012;98(1):60-64.
Kim YH, Oh HC, Choi JW, Hwang HY, Kim KB, Kim KB. No-touch saphenous vein harvesting may improve further the patency of saphenous vein composite grafts: early outcomes and 1-year angiographic results. Ann Thorac Surg. 2017;103(5):1489-1497.
Janiec M, Friberg Ö, Thelin S. Long-term clinical outcomes after coronary artery bypass grafting with pedicled saphenous vein grafts. J Cardiothorac Surg. 2018;13(1):122.
Kodia K, Patel S, Weber MP, et al. Graft patency after open versus endoscopic saphenous vein harvest in coronary artery bypass grafting surgery: a systematic review and meta-analysis. Ann Cardiothorac Surg. 2018;7(5):586-597.
Souza DS, Dashwood MR, Tsui JC, et al. Improved patency in vein grafts harvested with surrounding tissue: results of a randomized study using three harvesting techniques. Ann Thorac Surg. 2002;73(4):1189-1195.
Verma S, Lovren F, Pan Y, et al. Pedicled no-touch saphenous vein graft harvest limits vascular smooth muscle cell activation: the PATENT saphenous vein graft study. Eur J Cardiothorac Surg. 2014;45(4):717-725.
Cataldo G, Braga M, Pirotta N, et al. Factors influencing 1-year patency of coronary artery saphenous vein grafts. Studio Indobufene nel Bypass Aortocoronarico (SINBA). Circulation. 1993;88(5 Pt 2):Ii93-Ii98.
Antonopoulos AS, Odutayo A, Oikonomou EK, et al. Development of a risk score for early saphenous vein graft failure: an individual patient data meta-analysis. J Thorac Cardiovasc Surg. 2020;160(1):116-127.
Hayashi I, Kashima I, Yoshikawa E. The endoscopic no-touch saphenous vein harvesting technique. Multimed Man Cardiothorac Surg. 2020;2020.
Kiani S, Desai PH, Thirumvalavan N, et al. Endoscopic venous harvesting by inexperienced operators compromises venous graft remodeling. Ann Thorac Surg. 2012;93(1):11-17.

Auteurs

Yujiro Yokoyama (Y)

Department of Surgery, St. Luke's University Health Network, Pennsylvania, USA.

Junichi Shimamura (J)

Division of Cardiac Surgery, Department of Surgery, Western University, London Health Sciences Centre, Ontario, Canada.

Hisato Takagi (H)

Department of Cardiovascular Surgery, Shizuoka Medical Center, Shizuoka, Japan.

Toshiki Kuno (T)

Department of Medicine, Icahn School of Medicine at Mount Sinai, Mount Sinai Beth Israel, New York, USA.
Division of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH